Hyperoxia resensitizes chemoresistant human glioblastoma cells to temozolomide

[1]  A. Calkovska,et al.  Effect of Long-Term Normobaric Hyperoxia on Oxidative Stress in Mitochondria of the Guinea Pig Brain , 2011, Neurochemical Research.

[2]  T. Cloughesy,et al.  AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme , 2011, Advances in therapy.

[3]  J. Yates,et al.  Chemo-resistant protein expression pattern of glioblastoma cells (A172) to perillyl alcohol. , 2011, Journal of proteome research.

[4]  Yang Lu,et al.  1, 9-Pyrazoloanthrones Downregulate HIF-1α and Sensitize Cancer Cells to Cetuximab-Mediated Anti-EGFR Therapy , 2010, PloS one.

[5]  L. Denaro,et al.  Interaction of Hypoxia‐Inducible Factor‐1α and Notch Signaling Regulates Medulloblastoma Precursor Proliferation and Fate , 2010, Stem cells.

[6]  J. Sarkaria,et al.  Acquisition of Temozolomide Chemoresistance in Gliomas Leads to Remodeling of Mitochondrial Electron Transport Chain* , 2010, The Journal of Biological Chemistry.

[7]  C. Eberhart,et al.  Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres. , 2010, The American journal of pathology.

[8]  Gianluca Bontempi,et al.  Long-term in vitro treatment of human glioblastoma cells with temozolomide increases resistance in vivo through up-regulation of GLUT transporter and aldo-keto reductase enzyme AKR1C expression. , 2010, Neoplasia.

[9]  R. Scienza,et al.  Intratumoral Hypoxic Gradient Drives Stem Cells Distribution and MGMT Expression in Glioblastoma , 2010, Stem cells.

[10]  M. Poruchynsky,et al.  Potent inhibition of tumoral hypoxia-inducible factor 1α by albendazole , 2010, BMC Cancer.

[11]  G. Salvesen,et al.  Hyperoxia increases the uptake of 5-fluorouracil in mammary tumors independently of changes in interstitial fluid pressure and tumor stroma , 2009, BMC Cancer.

[12]  C. Tolias,et al.  Normobaric hyperoxia therapy for traumatic brain injury and stroke: a review , 2009, British journal of neurosurgery.

[13]  M. Yokouchi,et al.  Hyperbaric oxygen as a chemotherapy adjuvant in the treatment of osteosarcoma. , 2009, Oncology reports.

[14]  J. Martínez-Lage,et al.  [Usefulness of hyperbaric oxygen in the treatment of radionecrosis and symptomatic brain edema after LINAC radiosurgery]. , 2009, Neurocirugia.

[15]  K. Kalland,et al.  Hyperoxic Treatment Induces Mesenchymal-to-Epithelial Transition in a Rat Adenocarcinoma Model , 2009, PloS one.

[16]  V. Amberger-Murphy.  Hypoxia helps glioma to fight therapy. , 2009, Current cancer drug targets.

[17]  R. Mirimanoff,et al.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. , 2009, The Lancet. Oncology.

[18]  J. Olson,et al.  Acute hyperoxia increases lipid peroxidation and induces plasma membrane blebbing in human U87 glioblastoma cells , 2009, Neuroscience.

[19]  Allan H Friedman,et al.  Phase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant glioma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  M. Bullock,et al.  Hyperoxia and traumatic brain injury. , 2009, Journal of neurosurgery.

[21]  K. Kalland,et al.  Hyperoxia retards growth and induces apoptosis, changes in vascular density and gene expression in transplanted gliomas in nude rats , 2007, Journal of Neuro-Oncology.

[22]  E. Miller,et al.  Hyperoxia-induced signal transduction pathways in pulmonary epithelial cells. , 2007, Free radical biology & medicine.

[23]  A. Singhal.  A review of oxygen therapy in ischemic stroke , 2007, Neurological research.

[24]  P. Wen,et al.  Glioma Therapy in Adults , 2006, The neurologist.

[25]  S. Fesik,et al.  Hypoxia-Inducible Factor-1 Inhibition in Combination with Temozolomide Treatment Exhibits Robust Antitumor Efficacy In vivo , 2006, Clinical Cancer Research.

[26]  M. Sanson,et al.  Genetic alterations associated with acquired temozolomide resistance in SNB-19, a human glioma cell line , 2006, Molecular Cancer Therapeutics.

[27]  V. Band,et al.  Hyperbaric oxygen inhibits benign and malignant human mammary epithelial cell proliferation. , 2005, Anticancer research.

[28]  M. Staver,et al.  Evaluating hypoxia-inducible factor-1alpha as a cancer therapeutic target via inducible RNA interference in vivo. , 2005, Cancer research.

[29]  R. Mirimanoff,et al.  MGMT gene silencing and benefit from temozolomide in glioblastoma. , 2005, The New England journal of medicine.

[30]  O. Straume,et al.  Hyperbaric oxygen alone or combined with 5-FU attenuates growth of DMBA-induced rat mammary tumors. , 2004, Cancer letters.

[31]  H. Foda,et al.  [Pulmonary apoptosis and necrosis in hyperoxia-induced acute mouse lung injury]. , 2004, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases.

[32]  M. Birrer,et al.  MAPK pathways mediate hyperoxia-induced oncotic cell death in lung epithelial cells. , 2003, Free radical biology & medicine.

[33]  G. Semenza.  Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.

[34]  T. Standiford,et al.  Hyperoxia Mediates Acute Lung Injury and Increased Lethality in Murine Legionella Pneumonia: The Role of Apoptosis1 , 2003, The Journal of Immunology.

[35]  D. Brat,et al.  Malignant Glioma Physiology: Cellular Response to Hypoxia and Its Role in Tumor Progression , 2003, Annals of Internal Medicine.

[36]  S. Finkelstein,et al.  Multifaceted resistance of gliomas to temozolomide. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[37]  Akira Ogawa,et al.  Change of Oxygen Pressure in Glioblastoma Tissue Under Various Conditions , 2002, Journal of Neuro-Oncology.

[38]  C. D’Angio,et al.  Bcl-2 Family Gene Expression during Severe Hyperoxia Induced Lung Injury , 2000, Laboratory Investigation.

[39]  Mary E. Choi,et al.  Mitogen-activated protein kinase pathway mediates hyperoxia-induced apoptosis in cultured macrophage cells. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[40]  C. Peterson,et al.  Activated satellite cells fail to restore myonuclear number in spinal cord transected and exercised rats. , 1999, American journal of physiology. Cell physiology.

[41]  D. Warburton,et al.  ERK activation protects against DNA damage and apoptosis in hyperoxic rat AEC2. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[42]  J. Herman,et al.  Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. , 1999, Cancer research.

[43]  E. Krebs,et al.  The MAPK signaling cascade , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[44]  R. Buller,et al.  Evaluation of hyperbaric oxygen as a chemosensitizer in the treatment of epithelial ovarian cancer in xenografts in mice , 1995, Cancer.

[45]  J. Shenberger,et al.  Hyperoxia-induced activation of the integrated stress response in the newborn rat lung. , 2012, American journal of physiology. Lung cellular and molecular physiology.

[46]  J. Fernández-Pérez,et al.  Eficacia del oxígeno hiperbárico en el tratamiento de la radionecrosis y el edema cerebral sintomáticos tras radiocirugía con acelerador lineal , 2009 .

[47]  A. Chakravarti,et al.  Overcoming therapeutic resistance in malignant gliomas: current practices and future directions. , 2008, Cancer treatment and research.

[48]  N. Al-Waili,et al.  A combination of radiotherapy, nitric oxide and a hyperoxygenation sensitizing protocol for brain malignant tumor treatment. , 2007, Medical hypotheses.

[49]  K. Ogasawara,et al.  A Phase II Study of Radiotherapy after Hyperbaric Oxygenation Combined with Interferon-beta and Nimustine Hydrochloride to Treat Supratentorial Malignant Gliomas , 2004, Journal of Neuro-Oncology.

[50]  J. Spears,et al.  Hyperbaric oxygen as a chemotherapy adjuvant in the treatment of metastatic lung tumors in a rat model. , 2003, The Journal of thoracic and cardiovascular surgery.

[51]  N. Nakajima,et al.  Use of 5-FU plus hyperbaric oxygen for treating malignant tumors: evaluation of antitumor effect and measurement of 5-FU in individual organs , 2001, Cancer Chemotherapy and Pharmacology.

[52]  J. Kalns,et al.  The effect of hyperbaric oxygen on growth and chemosensitivity of metastatic prostate cancer. , 1998, Anticancer Research.

[53]  Philip J. R. Day,et al.  LABORATORY INVESTIGATION- HUMAN/ANIMAL TISSUE Protein , 2022 .